Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.

Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study. - Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033419

Enrollment

Registered

2018-07-18

Start date

2018-07-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver disease (exclude alcoholic hepatitis)

Interventions

Resistance training 4 month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosed as fatty liver 2. ALT >= 40 3. Aged over 20 years old and under 75 4. PS 0 - 1 (ECOG) 5. Patients who are able to provide written consent to participate in this research in person, follow instructions during participation in this research, and undergo protocol-specified physical examination and other examinations.

Exclusion criteria

Exclusion criteria: Decompensated cirrhosis, Affected malignant tumor in 2-years (exclude carcinoma in situ), heart and lung disease (NYHA > II), percutaneous coronary intervention in 6 month, proliferative diabetic retinopathy, diabetic patient using sulfonylurea / insulin, diabetic neuropathy, severe musculoskeletal impairment, gestation.

Design outcomes

Primary

Measure	Time frame
Improvement of ALT comparing between before and after intervention.	—

Secondary

Measure	Time frame
Laboratory data, Body composition analysis (BIA method), amount of physical exertion (activity meter), Specific Activity Scale, Athens Insomnia Scale. Concurrently, the efficacy of exercise is also studied in non-intervention group (the evaluation items are the same as above).	—

Countries

Japan

Contacts

Public ContactOkajima Akira

Takeda hospital Gastroenterology and hepatology

aokajima@koto.kpu-m.ac.jp+81-75-361-1351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026